NIH-funded research NIH-funded research

WePrEP: A bilingual tool to help transgender women and their providers pick the best PrEP method

Official title: WePrEP: A bilingual shared decision-making tool to facilitate conversations between transgender women and their providers as they select an ideal PrEP method

Funded at University of Colorado Denver · NIH-11378147 · Data updated 2026-11-12

A bilingual digital tool helps transgender women talk with their healthcare providers to choose between oral and injectable PrEP in a way that fits their needs and lifestyle.

More Decision Making research and trials

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of Colorado Denver
NIH-funded
Lab location1 site (Aurora, UNITED STATES)
Project startMay 1, 2024
Project endFebruary 28, 2027
Funding year2026
Award (this year)$222,197
NIH project number5R34MH136932-03
Project IDNIH-11378147 on NIH RePORTER

Who could benefit from this research

Could help

Transgender women and other women at risk for HIV who are considering PrEP options and interacting with PrEP providers.

Less likely to help

Women who are not considering PrEP or do not engage with PrEP services may not benefit directly.

What this research studies

This project creates and tests a bilingual, patient-friendly decision aid called WePrEP to support conversations about HIV prevention. It focuses on cisgender and transgender women who are evaluating PrEP options, including long-acting injectable cabotegravir. The team will pilot the tool with providers and patients to see how well it supports shared decision making and improves communication about pregnancy, lactation, and adherence considerations. The study will measure usability, acceptability, and potential impact on choosing an optimal PrEP method.

Why it matters

Potential benefit: If successful, WePrEP could help more women make informed PrEP choices and improve adherence by aligning prevention methods with their values and life circumstances.

How similar studies have gone: Related decision-support tools have shown promise in improving patient-provider communication, but this project tailors to women’s specific PrEP decisions and bilingual needs.

Where this research is happening

  • University of Colorado Denver
    Aurora, United States
    Active

Researchers

  • Principal investigator: Rael, Christine Tagliaferri — University of Colorado Denver
  • Study coordinator: Rael, Christine Tagliaferri

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.